Industry: Pharmaceuticals, Biotechnology
TranXenoGen specializes in the development of the application of second-generation transgenic technology for the production of high volume therapeutic proteins in the egg whites of transgenic chicken eggs. The objective is to provide a practical, effective production source for proteins in sufficient quantities to satisfy the increasing demand arising from the development of new protein-based drugs. The Company has under development four generic biological products, one research monoclonal antibody and four partners’ monoclonal antibody products. ( www.tranxenogen.com )
TranXenoGen , Inc.
800 Boston Turnpike
Shrewsbury, Massachusetts 01545
USA
Tel: (508) 936-4200